BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Policy

  FDA Cancels Advisory Committee Meeting To Review Wyeth’s Desvenlafaxine Succinate Data For Major Depressive Disorder

  August 22, 2006

   · 

  3 min read
• Business

  Althea Technologies, Inc. To Manufacture Altus Pharmaceuticals Inc.'s ALTU-238 Human Growth Hormone For Phase III Studies

  August 22, 2006

   · 

  1 min read
• FDA

  Bovie Medical Corporation Announces The Filing Of An FDA 510(k) Application For New Laparoscopic

  August 22, 2006

   · 

  1 min read
• Drug Development

  INNOVIVE Pharmaceuticals Licenses Anthracycline Prodrug; Phase II Development In Solid Tumors Will Start Shortly

  August 22, 2006

   · 

  1 min read
• Drug Development

  MethylGene’s HDAC Inhibitor, MGCD0103, Enters Phase II Clinical Trial In Patients With Refractory Or Relapsed Hodgkin’s Lymphoma

  August 22, 2006

   · 

  1 min read
• Genetown

  Caliper Life Sciences, Inc. CEO To Ring The NASDAQ Stock Market Opening Bell

  August 22, 2006

   · 

  1 min read
• Pharm Country

  Test Kitchen Method Fosters Product And Process Innovation Chemical Developer Releases Guide On Product Innovation

  August 22, 2006

   · 

  1 min read
• Business

  Prestwick Pharmaceuticals, Inc. Appoints George F. Horner III As President And Chief Executive Officer

  August 22, 2006

   · 

  1 min read
• WuXi PharmaTech Co., Ltd. Attends The IBC Life Sciences’s 11th Annual World Congress

  August 22, 2006

   · 

  1 min read
• Business

  Howard D. Goldstein Takes CEO Position At Arcxis Biotechnologies

  August 22, 2006

   · 

  1 min read